Development of Procathepsin L (pCTS-L)-Inhibiting Lanosterol-Carrying Liposome Nanoparticles to Treat Lethal Sepsis
Weiqiang Chen(Nanyang Technological University), Haichao Wang(Feinstein Institute for Medical Research)
Cited by 10
Related Papers
Monoclonal Antibodies Capable of Binding SARS-CoV-2 Spike Protein Receptor Binding Motif Specifically Prevent GM-CSF Induction
|bioRxiv (Cold Spring Harbor Laboratory)|2020|4
Repurposing a detrimental antibody epitope as targeted therapeutics for sepsis and rheumatoid arthritis
|Military Medical Research|2026|2